Device Trial Radar · NCT03222375
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
Last checked: Nov 20, 2026Latest source record: Nov 28, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Sep 26, 2017
Primary completion
Sep 2022
Study completion Dec 2027
Sponsor
- Lead sponsor
- American Federation of Medical SynergeticsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Clinic of Synergetics, Department of Neurology/Neuropsychology WOMS; Institute of Medical Synergetics, Department of Cognitive Neurology WOMS; Laboratory of Neurocomputational Active Media WOMS; SQUED, Inc., USA; Center of Synergetics, Universität Stuttgart, Germany; Ivan Franko National University of Lviv, Ukraine; Danylo Halytsky Lviv National Medical University; World Organization of Medical Synergetics; World Autism Center, American Federation of Medical Synergetics
- First posted
- Jul 19, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 1 month, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Locomotor, transport and information functions in human body systems are carried out by active media in autowave regimes! Any living organism is a (micro-macro-mega) hierarchy of autowave subsystems-an ensemble of loosely coupled subsystems of a simpler structure. From the highest levels of the hierarchy, Autowave Codes-Signals arrive, which determine the transitions of subsystems from one autowave regime to another Autowave interaction (of Complex Coherent Action). Autowave interaction is a process associated with the evolution and interaction of spatial and wave structures in the active media of the organism. Chaos in organism functioning tells about health. Periodicity - Autowave reverberator may presage a disease - Autism Spectrum Disorder; Chaotic nature of oscillations in active media of physiological systems is more optimal for their vital functions than periodic one. Firstly, systems that function in chaotic regimes, can re-arrange themselves faster and easier in case of change of environmental conditions, i.e. the so called adaptive control is more easily implemented in them. Secondly, "spreading" of oscillations strength along comparatively wide frequency band takes place in chaotic regime. When an organism is young and healthy, physiological systems show the elements of chaotic behavior, i.e. irregularity and chaotic dynamics are the extremely important characteristics of health. Decrease in changeability and appearance of stable periodicity of Autowave reverberator are often connected with Autism. The main purpose is to study brain plasticity (the changes that occur in the brain through Autowave reverberator) in children with autism. Research suggests that during development, the brains of children may change in response to their Autowave reverberator differently than the brains of typically developing individuals. Investigators want to understand why and how this difference may contribute to the symptoms of autism spectrum disorder (ASD). In this study, the investigators will be examining the effects of non-invasive neuromodulation SQUED™ series 28.1 home-use for Treatment of Autowave reverberator of Autism. Integrative Team World Organization of Medical Synergetics (WOMS) - collaborations between physicians and researchers with expertise in biostatistics, physics, mathematics, engineering, and computer science.
Conditions
- Autistic Disorder
- Autism Spectrum Disorder
- Child Development Disorders, Pervasive
- Neurodevelopmental Disorders
- Mental Disorders
- Asperger's Syndrome
- Neurobehavioral Manifestations
- Nervous System Diseases
Interventions
SQUED™ series 28.1 home-useDevice
Semiconducting QUantum Excitonic Device - artifificial active medium, where the processes of self-organization lead to creation and converter of Autowaves energy. Some autowaves have the properties of quasi-particles!
Primary outcomes
What the sponsor says the trial is designed to measure.
- SQUED™ software of patientTime frame: Personal Autowave Diagnostics/Personal Autowave Therapy - through study completion, an average of 1 year
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
World Autism Center, American Federation of Medical Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology WOMS
Louisville, Kentucky · Recruiting
Clinic of Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology of the World Organization of Medical Synergetics
Lviv, Solonka Village, Urozayna Street 41, Ukraine · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.